Abstract

Copper oxide nanoparticles are among the metal nanoparticles gaining popularity in many biotechnological fields, particularly in marine environments. Their antimicrobial and antibiofilm activities make them appealing to many researchers. Among the various methods of producing nanoparticles, biosynthesis is crucial. Thus, a large number of reports have been made about the microbiological manufacture of these nanoparticles by bacteria. Nevertheless, bio-production by means of the cell-free supernatant of marine bacteria is still in its primary phase. This is landmark research to look at how bacteria make a lot (14 g/L) of copper oxide nanoparticles (CuO-NPs) via the cell-free supernatant of Bacillus siamensis HS, their characterization, and their environmental and medical approaches. The biosynthesized nanoparticles were characterized using a UV–visible spectrum range that provides two maximum absorption peaks, one obtained at 400 nm and the other around 550–600 nm. Diffraction of X-rays (XRD) clarifies that the size of the NPs obtained was estimated to be 18 nm using Debye-Scherrer's equation. Scanning electron microscope-energy dispersive X-ray spectroscopy (SEM-EDX) displays 91.93 % copper oxide purity. The Transmission Electron Microscope (TEM) image proves that the particles have a spherical form and an average diameter of 6.54–8.60 nm. At the environmental level, nanoparticles incorporated into oil-based paint can be used as antibiofilm tools to diminish the biofilm formed on the submerged surface in the marine environment. In disease management, NPs can be used as a wound healing agent to reduce the wound gap size as well as an anti-tumour agent to control liver cancer cells (hepatoma cells (HepG2)).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call